For veterans with service-connected diabetes — whether through Agent Orange presumption, Gulf War illness, or the PACT Act — diabetic peripheral neuropathy represents one of the highest-value secondary claims available in the VA system. The reason is structural: neuropathy affecting the arms, hands, legs, and feet is rated separately for each affected limb, with a bilateral factor applied on top. Under Diagnostic Codes 8510 through 8530, a veteran with moderate neuropathy in both lower extremities can add two separate ratings to their combined calculation plus the bilateral factor bonus — a significant jump in combined disability and monthly compensation. This guide covers the service connection chain, DC 8520 rating criteria, bilateral strategy, required evidence, and how neuropathy fits into the broader diabetes secondary claim portfolio.
Most VA disability claims involve a single rating for a single condition. Diabetic peripheral neuropathy breaks that pattern in a way that is uniquely favorable to veterans. The VA rates nerve damage in each affected peripheral nerve separately — meaning if your diabetes has caused neuropathy in your right leg, your left leg, your right arm, and your left arm, each of those can receive its own rating under the applicable diagnostic code. The bilateral factor then applies an additional mathematical enhancement to paired limb disabilities.
Consider the structural difference between a veteran with 30% diabetes (a single condition, single rating) versus that same veteran who also files for moderate bilateral lower extremity neuropathy secondary to the diabetes: two additional 20% ratings plus bilateral factor. The combined calculation produces a substantially higher overall percentage — translating directly to hundreds of additional dollars per month for the rest of the veteran's life.
Yet despite this potential, thousands of veterans with service-connected diabetes never file for neuropathy. The most common reasons: they don't know it's claimable as secondary, they assume the symptoms are "just diabetes," or they were told at a C&P exam for diabetes that nerve symptoms were "part of the diabetes rating." That last piece of guidance is typically wrong — neuropathy is separately ratable under its own diagnostic code.
Diabetic peripheral neuropathy is rated separately from diabetes mellitus. The VA rates each affected limb under its own diagnostic code (DC 8510–8530). These are not included in the diabetes rating under DC 7913. Filing for neuropathy as secondary to service-connected diabetes is a distinct claim that produces a distinct, additional rating.
The legal pathway for this claim runs through 38 CFR 3.310, the secondary service connection regulation. The chain has three links:
The medical basis for the connection is straightforward and widely accepted in clinical medicine. Chronic hyperglycemia — elevated blood glucose — damages the myelin sheaths and axons of peripheral nerves through multiple mechanisms: oxidative stress, advanced glycation end-product accumulation, reduced nerve blood flow, and direct metabolic toxicity. The result is progressive peripheral neuropathy, typically beginning in the distal extremities (feet and toes) and moving proximally — the classic "stocking-glove" pattern of diabetic neuropathy.
Because this is a well-established, mechanistically understood medical relationship, the nexus for diabetic peripheral neuropathy secondary to service-connected diabetes is typically straightforward to establish. Unlike some secondary claims where the causal connection requires extensive argumentation, the diabetes-neuropathy link is considered a recognized complication in all standard clinical guidelines. A treating physician's note documenting diabetic neuropathy as a complication of the patient's diabetes, combined with objective test results (EMG/NCS), is generally sufficient.
The first step for many veterans is establishing diabetes itself as service connected. Two major presumptive pathways exist:
Type 2 diabetes mellitus is a presumptive condition for veterans exposed to Agent Orange (herbicide) during service. Veterans who served in Vietnam between January 9, 1962, and May 7, 1975; veterans who served in the Korean DMZ; veterans who served in certain other locations with documented herbicide use; and certain Air Force veterans who handled or maintained C-123 aircraft used to spray Agent Orange are all covered by this presumption.
If you are a covered Vietnam-era veteran and you have been diagnosed with Type 2 diabetes mellitus, you do not need to prove that diabetes is connected to your service. The VA presumes the connection. This automatic service connection for diabetes then becomes the anchor for peripheral neuropathy as secondary.
The PACT Act of 2022 significantly expanded presumptive service connection for veterans exposed to burn pits, toxic airborne hazards, and other environmental exposures during service after August 2, 1990. Under the PACT Act, additional conditions are being added to the presumptive list, and Gulf War illness is a recognized condition for veterans who served in Southwest Asia.
Veterans who served in covered locations and subsequently developed diabetes should consult the PACT Act tool to evaluate whether their diabetes qualifies for presumptive service connection, which then opens the neuropathy secondary pathway. The PACT Act's provisions are still being implemented, and eligibility for specific conditions continues to expand.
For veterans who don't qualify for presumptive status, direct service connection for diabetes is possible if service treatment records document diabetes onset during service, or if a nexus can be established between service exposures and the development of diabetes. This pathway requires a nexus letter and more robust evidence but remains viable for many veterans.
Peripheral nerve conditions are rated under 38 CFR Part 4, Schedule for Rating Disabilities, under the neurological conditions section. The relevant codes are:
For diabetic peripheral neuropathy affecting the lower extremities — by far the most common pattern — DC 8520 (Sciatic Nerve) is the most frequently applied code, as it covers the major nerve trunk of the lower extremity and its symptoms most closely match the diffuse lower extremity neuropathy of diabetes. The C&P examiner will determine the most appropriate code based on the pattern of nerve involvement documented in your EMG/NCS and clinical records.
Peripheral neuropathy rated under DC 8520 (and the other nerve codes) uses a five-tier scale based on the degree of paralysis — from incomplete (mild functional impairment) to complete (severe functional loss). The terminology of "paralysis" in the rating criteria does not mean total loss of movement; it describes the severity of nerve dysfunction along a spectrum:
| Rating | Level of Paralysis | Clinical Features |
|---|---|---|
| 10% | Mild incomplete paralysis | Intermittent symptoms — numbness, tingling, mild weakness; symptoms come and go, may worsen with activity or at night |
| 20% | Moderate incomplete paralysis | More constant symptoms, moderate sensory loss (diminished sensation to light touch or pinprick), mild to moderate weakness; may affect balance and gait |
| 40% | Moderately severe incomplete paralysis | Significant muscle weakness, more pronounced sensory deficits, difficulty with coordinated movements, notable gait impairment |
| 60% | Severe incomplete paralysis | Foot drop, significant muscle atrophy, severe sensory loss, marked functional impairment — requires assistive device or cannot walk without difficulty |
| 80% | Complete paralysis | Total functional loss of the nerve — complete loss of motor and sensory function in the affected distribution (rare in diabetic neuropathy) |
Most veterans with diabetic peripheral neuropathy will fall into the 10% to 40% range. The 10% and 20% ratings are the most common for early to moderate diabetic neuropathy. The 40% rating applies to veterans with significant functional impairment — notable weakness, difficulty with stairs or uneven surfaces, balance problems that affect daily function.
The critical point for your C&P examination: document your worst symptoms, not your average day. Diabetic neuropathy often worsens at night, worsens with prolonged standing or walking, and fluctuates with glycemic control. The rating should reflect the full picture of your condition across your range of experience, not just how you happened to feel on exam day.
This is the aspect of diabetic neuropathy claims that generates the most significant financial impact — and the aspect that most veterans and even many VSOs overlook.
When neuropathy affects both lower extremities — both legs and feet, which is the typical pattern in diabetic peripheral neuropathy — the veteran files a separate claim for each affected limb. Each limb receives its own rating. If the neuropathy is moderate in both extremities, the veteran receives two 20% ratings.
The bilateral factor, codified in 38 CFR 4.68, adds an additional 10% to the combined value of bilateral disabilities affecting paired limbs or paired sense organs. Here is how the math works for bilateral 20% lower extremity neuropathy:
| Step | Calculation | Result |
|---|---|---|
| Right lower extremity neuropathy | DC 8520, 20% | 20% |
| Left lower extremity neuropathy | DC 8520, 20% | From 80% remaining efficiency = 16% |
| Combined before bilateral factor | 20% + 16% | 36% |
| Bilateral factor (10% of 36%) | 3.6% | +3.6% |
| Total bilateral neuropathy value | 39.6%, rounds to 40% | ~40% |
That combined bilateral neuropathy value then enters the overall combined ratings calculation with all your other service-connected conditions, potentially pushing you from one rating tier to the next. The bilateral factor is not optional — the VA is required to apply it when the bilateral rule is met. Make sure you claim both limbs explicitly and that your C&P examiner evaluates both sides.
When you file for diabetic peripheral neuropathy, explicitly claim both the right and left affected extremities as separate line items on your VA Form 21-526EZ. Do not lump them together as "bilateral neuropathy" — list them as: "Peripheral neuropathy, right lower extremity, secondary to service-connected diabetes mellitus" and "Peripheral neuropathy, left lower extremity, secondary to service-connected diabetes mellitus." This ensures each receives an individual rating and the bilateral factor is applied.
The most important objective evidence for a diabetic peripheral neuropathy claim is a nerve conduction study (NCS) and electromyography (EMG). This combined test, performed by a neurologist or physiatrist, directly measures nerve conduction velocity, amplitude, and latency — providing objective documentation of nerve damage that the VA's C&P examiners and raters accept as definitive proof of neuropathy.
If you do not yet have an EMG/NCS, request one from your VA neurologist or primary care provider. This is a standard diagnostic test for neuropathy symptoms and should be readily available through the VA. A private neurologist can also perform the study. Without objective nerve conduction evidence, VA raters may assign a lower rating or deny on the basis of insufficient objective evidence.
A common misconception prevents many veterans from filing: they assume that because neuropathy developed years — sometimes decades — after their diabetes was diagnosed, the connection cannot be established or the claim is time-barred. This is incorrect on both counts.
Diabetic peripheral neuropathy is a progressive complication that typically develops over years to decades of diabetes. The American Diabetes Association notes that approximately 50 percent of people with diabetes will develop peripheral neuropathy, with risk increasing with duration of diabetes and degree of glycemic control. Developing neuropathy 10 or 15 years after a diabetes diagnosis is entirely consistent with the natural history of the disease — not evidence against the claim.
The effective date for compensation will generally be the date of your claim (or up to one year before, if you can show symptoms existed before you filed). You are not penalized for the progressive nature of the complication. The nexus remains fully supportable: long-standing service-connected diabetes has, over time, produced the peripheral neuropathy now documented by EMG/NCS and clinical examination.
If you were diagnosed with neuropathy years ago but never filed for VA compensation, an informal claim date may be established from the date of that original diagnosis in your VA records. Speak with a VA-accredited representative about the effective date implications for your specific situation.
Peripheral neuropathy is the most common and highest-value secondary to diabetes, but it is far from the only one. Veterans with service-connected diabetes should evaluate the full landscape of secondary claims:
Diabetes damages the microvasculature of the retina, causing progressive vision loss. Diabetic retinopathy is rated based on visual acuity impairment. Even mild visual field or acuity changes can produce ratable disabilities, and severe retinopathy causing significant vision loss can generate substantial ratings. If you are seeing an ophthalmologist for diabetes-related eye changes, request your full records and consider filing secondary to diabetes.
Chronic kidney disease is a well-recognized complication of long-standing diabetes, mediated by the same microvascular damage mechanisms as retinopathy. Kidney disease is rated based on renal function — GFR, creatinine, proteinuria. Veterans with diabetes who have received nephrology referrals or have documented reduced kidney function may have a viable secondary claim.
Diabetic autonomic neuropathy affecting penile vascular and nerve function is one of the most common causes of erectile dysfunction in male veterans. ED secondary to service-connected diabetes is claimable under DC 7522 (20% flat rating) plus Special Monthly Compensation K ($121.06/mo in 2025). This is a separate claim from neuropathy with its own rating structure.
Diabetes is a major risk factor for peripheral arterial disease — narrowing of the arteries in the legs. PAD secondary to diabetes can be rated under the peripheral vascular disease codes and is distinct from neuropathy. If you have symptoms of claudication, reduced ankle-brachial index, or documented arterial stenosis, this may be an additional secondary claim.
Consider a Vietnam veteran with existing ratings:
30% diabetes mellitus (DC 7913) = approximately $503/mo as a single condition
Adding bilateral lower extremity neuropathy at 20% each (moderate, DC 8520 bilateral):
Combined calculation: 30% + bilateral neuropathy (~39.6% → 40% effective bilateral value)
Combined ~58% → rounds to 60% → approximately $1,319/mo
That represents roughly $816/mo more than diabetes alone — for life. If neuropathy is moderately severe (40% each limb) the combined jumps even higher. Use the rating estimator and disability calculator to calculate your specific scenario with your current rating mix.
Your diabetes must be service connected before you can file neuropathy as secondary. If diabetes is already on your rating, you are ready to proceed. If not, use the PACT Act tool to evaluate Agent Orange or PACT Act eligibility, then file for diabetes first. You can file for diabetes and neuropathy simultaneously — the secondary claim will be processed once the primary is established.
Contact your VA neurology or primary care provider to request a nerve conduction study. If you already have EMG/NCS results in your records, pull them. This is the cornerstone objective evidence for the claim.
Pull endocrinology records, neurology notes, podiatry records, and any other documentation of neuropathy symptoms or treatment. Request pharmacy records showing prescriptions for gabapentin, pregabalin, duloxetine, or other neuropathy medications.
Document how neuropathy affects your daily life: balance issues, falls, inability to stand for extended periods, nighttime pain disrupting sleep, inability to feel foot injuries (creating infection risk), limited walking distance. The rating formula is based on functional impact — make the functional impact concrete and specific.
List each affected extremity as a separate claim line. For bilateral lower extremity neuropathy: "Peripheral neuropathy, right lower extremity, secondary to service-connected diabetes mellitus, DC 8520" and "Peripheral neuropathy, left lower extremity, secondary to service-connected diabetes mellitus, DC 8520." Upload all supporting evidence with the claim submission.
The VA will likely schedule a C&P examination with a neurologist or general physician. Bring your EMG/NCS results if they were not submitted with the claim. Walk the examiner through your symptoms in both extremities — don't let the exam focus only on the more severely affected side. Both limbs need to be documented to support the bilateral ratings.
claim.vet helps veterans identify secondary conditions from diabetes and other service-connected conditions, build complete evidence packages, and file claims that maximize compensation.
Start Your Claim →Use the rating estimator to model bilateral neuropathy ratings, the PACT Act tool to evaluate Agent Orange and burn pit presumptive eligibility, and the disability calculator to see your exact monthly compensation at your new combined rating.